You are here

  • Home
  • Archive
  • Volume 72, Issue 9
  • Dataset for the reporting of renal biopsy for tumour: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Article Text

Article menu
Download PDFPDF
Review
Dataset for the reporting of renal biopsy for tumour: recommendations from the International Collaboration on Cancer Reporting (ICCR)
  1. Brett Delahunt1,
  2. John R Srigley2,
  3. Meagan Judge3,
  4. Mahul Amin4,
  5. Athanase Billis5,
  6. Philippe Camparo6,
  7. Stewart Fleming7,
  8. David Griffiths8,
  9. Antonio Lopez-Beltran9,
  10. Guido Martignoni10,
  11. Holger Moch11,
  12. John N Nacey12,
  13. Ming Zhou13,
  14. Andrew John Evans14
  1. 1 Department of Pathology and Molecular Medicine, Wellington Sch Med, Wellington, New Zealand
  2. 2 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
  3. 3 Royal College of Pathologists of Australasia, Surry Hills, New South Wales, Australia
  4. 4 Department of Pathology and Laboratory medicine, University of Tennessee Health Sciences, Memphis, Tennessee, USA
  5. 5 Department of Anatomic Pathology, Universidade Estadual de Campinas, Campinas, Brazil
  6. 6 Service d'anatomie et cytologie pathologiques, Hopital Foch, Paris, France
  7. 7 Department of Cellular and Molecular Pathology, University of Dundee, Dundee, UK
  8. 8 Department of Pathology, University Hospital of Wales, Cardiff, UK
  9. 9 Department of Pathology and Surgery, Cordoba University Medical School, /Cordoba, Spain
  10. 10 Anatomia Patologica, Department of Pathology and Diagnostics, University of Verona, Verona, Italy
  11. 11 Department of Pathology, Institute for Surgical Pathology, University Hospital, Zurich, Switzerland
  12. 12 Department of Surgery and Anaesthesia, Wellington Sch Med, Wellington, New Zealand
  13. 13 Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
  14. 14 Department of Pathology, University Health Network, Toronto, Ontario, Canada
  1. Correspondence to Dr Brett Delahunt, Pathology and Molecular Medicine, Wellington Sch Med, Wellington 6021, New Zealand; brett.delahunt{at}otago.ac.nz

Abstract

The International Collaboration on Cancer Reporting (ICCR) has developed a suite of detailed datasets for international implementation. These datasets are based on the reporting protocols developed by the Royal College of Pathologists (UK), The Royal College of Pathologists of Australasia and the College of American Pathologists, with modifications undertaken by international expert groups appointed according to ICCR protocols. The dataset for the reporting of renal biopsy for tumour is designed to provide a structured reporting template containing minimum data recording key elements suitable for international use. In formulating the dataset, the ICCR panel incorporated recommendations from the 2012 Vancouver Consensus Conference of the International Society of Urological Pathology (ISUP) and the 2016 edition of the WHO Bluebook on tumours of the urinary and male genital systems. Reporting elements were divided into Required (Core) and Recommended (Non-core) components of the report. Required elements are as follows: specimen laterality, histological tumour type, WHO/ISUP histological tumour grade, sarcomatoid morphology, rhabdoid morphology, necrosis, lymphovascular invasion and coexisting pathology in non-neoplastic kidney. Recommended reporting elements are as follows: operative procedure, tumour site(s), histological tumour subtype and details of ancillary studies. In particular, it is noted that fluorescence in situ hybridisation studies may assist in diagnosing translocation renal cell carcinoma (RCC) and in distinguishing oncocytoma and eosinophilic chromophobe RCC. It is anticipated that the implementation of this dataset into routine clinical practice will facilitate uniformity of pathology reporting worldwide. This, in turn, should have a positive impact on patient treatment and the quality of demographic information held by cancer registries.

  • renal cell carcinoma
  • biopsy
  • dataset
  • tumour
  • grading

https://doi.org/10.1136/jclinpath-2019-205959

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Handling editor Dhirendra Govender.

    • Contributors All authors contributed to the content of the database. BD and MJ wrote the manuscript. All authors provide comment on the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.